Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 20/20 | 0.44 |
| ▸ | MMP14 | P50281 | 10/20 | 0.44 |
| ▸ | MMP12 | P39900 | 5/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL942669 | 1.00 | MMP13 (0.44) | MMP13MMP14MMP12 | |
| SCHEMBL940852 | 0.91 | MMP13 (0.53) | MMP13MMP14MMP12 | |
| SCHEMBL2289321 | 0.86 | MMP13 (0.43) | MMP13MMP14MMP12 | |
| SCHEMBL5241113 | 0.86 | MMP13 (0.43) | MMP13MMP14MMP12 | |
| SCHEMBL5097147 | 0.85 | MMP13 (0.44) | MMP13MMP14MMP12 | |
| SCHEMBL8143638 | 0.85 | MMP13 (0.41) | MMP13MMP14MMP12 | |
| SCHEMBL5103259 | 0.84 | MMP13 (0.48) | MMP13MMP14MMP12 | |
| SCHEMBL5090731 | 0.84 | MMP13 (0.44) | MMP13MMP14MMP12 | |
| SCHEMBL5103261 | 0.84 | MMP13 (0.48) | MMP13MMP14MMP12 | |
| SCHEMBL5103016 | 0.84 | MMP13 (0.44) | MMP13MMP14MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040147573-A1 | Metalloproteinase inhibitors | ASTRAZENECA AB (SE) | 2004-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147573-A1 | Metalloproteinase inhibitors | MMP12, MMP7, MMP10 | MMP13 19/4885MMP14 10/4885MMP12 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.